Ikarian Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$21.6K Sell
2023
Q4
$8.51M Buy
2023
Q3
Hold
2022
Q2
Sell
2022
Q1
$274K Buy
2021
Q4
$262K Sell
2021
Q3
$380K Sell
2021
Q2
$1.08M Hold
2021
Q1
$1.22M Buy
2020
Q4
Hold